Primary Record
Ixazomib citrate
- In stock
- 3,082 g
- Purity
- 98.4 %
- CAS
- 1239908-20-3
Compound Identifiers & Properties
- CAS
- 1239908-20-3
- PubChem CID
- 56844015
- SMILES
- B1(OC(=O)C(O1)(CC(=O)O)CC(=O)O)[C@H](CC(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)Cl)Cl
- Canonical SMILES
- CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B1OC(=O)C(CC(=O)O)(CC(=O)O)O1
Names & Synonyms
- Ixazomib citrate
- NINLARO
- 1239908-20-3
- MLN9708
- Ixazomib
- Lxazomib Citrate
- Ixazomib citrate (Ester)
- Ixazomib citrate [USAN]
- Ninlaro (TN)
- Ixazomib Intermediates
- UNII-46CWK97Z3K
- 46CWK97Z3K
- MLN 9708
- MLN-9708
- Ixazomib Citrate (MLN9708)
- C20H23BCl2N2O9
- IXAZOMIB CITRATE [MI]
- Ixazomib citrate (JAN/USAN)
- IXAZOMIB CITRATE [JAN]
- orb1298968
- SCHEMBL4427479
- CHEMBL3545432
- SCHEMBL29354216
- CHEBI:90939
- KS-00000TRH
- DTXSID60924652
- IXAZOMIB CITRATE [WHO-DD]
- MBOMYENWWXQSNW-AWEZNQCLSA-N
- MFCD29767859
- GLXC-10711
- BCP16600
- EX-A3660
- Ixazomib Citrate (MLN-9708)?
- BBF-04173
- NSC767907
- s4432
- AKOS030632768
- C20-H23-B-Cl2-N2-O9
- IXAZOMIB CITRATE [ORANGE BOOK]
- Ixazomib Impurity N; Ixazomib Citrate
- ZINC200299610
- CS-1720
- NSC-767907
- NCGC00522453-01
- NCGC00522453-02
- AC-35344
- AS-75031
- DA-54493
- HY-10452
- C71946
- D10131
- (R)-2,2'-(2-(1-(2-(2,5-Dichlorobenzamido)acetamido)-3-methylbutyl)-5-oxo-1,3,2-dioxaborolane-4,4-diyl)diacetic acid
- 1,3,2-Dioxaborolane-4,4-diacetic acid, 2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-
- A857536
- F787571
- BRD-K15203492-001-01-1
- MLN9708; MLN-9708; MLN 9708;Ixazomib-prodrug
- Q27162929
- 2-[4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolan-4-yl]acetic acid
- 1,3,2-Dioxaborolane-4,4-diacetic acid, 2-((1R)-1-((2-((2,5-dichlorobenzoyl)amino)acetyl)amino)-3-methylbutyl)-5-oxo-
- 2,2'-{2-[(1R)-1-({[(2,5-dichlorobenzoyl)amino]acetyl}amino)-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diyl}diacetic acid
- 2,2'-{2-[(1R)-1-{[N-(2,5-dichlorobenzoyl)glycyl]amino}-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diyl}diacetic acid
- 2-[(1R)-1-[[2-[(2,5-Dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diacetic acid
- 2-[4-(carboxymethyl)-2-[(1R)-1-{2-[(2,5-dichlorophenyl)formamido]acetamido}-3-methylbutyl]-5-oxo-1,3,2-dioxaborolan-4-yl]acetic acid
- 1,3,2-Dioxaborolane-4,4-diacetic acid, 2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino] acetyl] amino]-3-methylbutyl]-5-oxo-
- 2,2'-(2-((1R)-1-((N-(2,5-DICHLOROBENZOYL)GLYCYL)AMINO)-3-METHYLBUTYL)-5-OXO-1,3,2-DIOXABOROLANE-4,4-DIYL)DIACETIC ACID
- 2,2'-{2-[(1R)-1-({[(2,5-dichlorobenzoy)amino]acetyl}amino)-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diyl}diacetic acid
- 2,2'-{2-[(1R)-1-{[N-(2,5-dichlorobenzoyl)glycyl]amino}-3-methylbutyl]-5-oxo-1,3,2- dioxaborolane-4,4-diyl}diacetic acid
- 2-[4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methyl-butyl]-5-oxo-1,3,2-dioxaborolan-4-yl]acetic acid
- 4-(carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid